ÂÜÀòÂÒÂ×

Thijn Brummelkamp is a Professor of Experimental Genetics at Universitair Medisch Centrum Utrecht and the Co-Founder of Scenic Biotech. Thijn is also a Group leader at Oncode Institute, The Netherlands Cancer Institute, and Haplogen. With a PhD in Cancer Research from Netherands Cancer Institute/Utrecht University and a Master of Science (MSc) in Biology from Free University, Amsterdam, Thijn Brummelkamp has a wealth of experience in the field. Additionally, Thijn has served as an Adjunct Principal Investigator at CeMM and as a Whitehead Fellow at Whitehead Institute.